National Drug Code (NDC) Database

Patheon Manufacturing Services LLC

  • NDC:

    63552-725

  • Nonproprietary Name:

    plerixafor

  • Dosage Form:

    INJECTION, SOLUTION

  • Product Type:

    DRUG FOR FURTHER PROCESSING

  • Strength:

    24 mg/1.2mL

  • Substance:

    PLERIXAFOR

  • Start Marketing Date:

    2025-09-01

  • End Marketing Date:

    0000-00-00

  • DEA Schedule:

  • Certified Through:

    2026-12-31

Patheon Softgels B.V.

  • NDC:

    68279-002

  • Nonproprietary Name:

    icosapent ethyl

  • Dosage Form:

    CAPSULE

  • Product Type:

    DRUG FOR FURTHER PROCESSING

  • Strength:

    500 mg/1

  • Substance:

    ICOSAPENT ETHYL

  • Start Marketing Date:

    2016-09-16

  • End Marketing Date:

    0000-00-00

  • DEA Schedule:

  • Certified Through:

    2026-12-31

Patheon Softgels Inc

  • NDC:

    10888-5041

  • Nonproprietary Name:

    CYCLOSPORINE

  • Dosage Form:

    CAPSULE, LIQUID FILLED

  • Product Type:

    DRUG FOR FURTHER PROCESSING

  • Strength:

    25 mg/1

  • Substance:

    CYCLOSPORINE

  • Start Marketing Date:

    2008-12-01

  • End Marketing Date:

    0000-00-00

  • DEA Schedule:

  • Certified Through:

    2026-12-31

Patheon Softgels Inc.

  • NDC:

    10888-8282

  • Nonproprietary Name:

    Ibuprofen

  • Dosage Form:

    CAPSULE, LIQUID FILLED

  • Product Type:

    DRUG FOR FURTHER PROCESSING

  • Strength:

    200 mg/1

  • Substance:

    IBUPROFEN

  • Start Marketing Date:

    2025-07-17

  • End Marketing Date:

    0000-00-00

  • DEA Schedule:

  • Certified Through:

    2027-12-31

Patheon Softgels, Inc.

  • NDC:

    10888-8270

  • Nonproprietary Name:

    Naproxen Sodium

  • Dosage Form:

    CAPSULE, LIQUID FILLED

  • Product Type:

    DRUG FOR FURTHER PROCESSING

  • Strength:

    220 mg/1

  • Substance:

    NAPROXEN SODIUM

  • Start Marketing Date:

    2023-06-27

  • End Marketing Date:

    0000-00-00

  • DEA Schedule:

  • Certified Through:

    2026-12-31

Patheon, Inc.

  • NDC:

    63285-894

  • Nonproprietary Name:

    adagrasib

  • Dosage Form:

    TABLET, COATED

  • Product Type:

    DRUG FOR FURTHER PROCESSING

  • Strength:

    200 mg/1

  • Substance:

    ADAGRASIB

  • Start Marketing Date:

    2022-12-12

  • End Marketing Date:

    0000-00-00

  • DEA Schedule:

  • Certified Through:

    2026-12-31

PCAS FINLAND

  • NDC:

    51014-7863

  • Nonproprietary Name:

    DISOPYRAMIDE PHOSPHATE

  • Dosage Form:

    POWDER

  • Product Type:

    BULK INGREDIENT

  • Strength:

    1 kg/kg

  • Substance:

    DISOPYRAMIDE PHOSPHATE

  • Start Marketing Date:

    2010-04-26

  • End Marketing Date:

    0000-00-00

  • DEA Schedule:

  • Certified Through:

    2026-12-31

PCAS Finland Oy

  • NDC:

    51014-7945

  • Nonproprietary Name:

    Hemin

  • Dosage Form:

    POWDER

  • Product Type:

    BULK INGREDIENT

  • Strength:

    1 g/g

  • Substance:

    HEMIN

  • Start Marketing Date:

    2019-12-18

  • End Marketing Date:

    0000-00-00

  • DEA Schedule:

  • Certified Through:

    2026-12-31

Patheon

+178

  • NDC:

    68225-253

  • Nonproprietary Name:

    ustekinumab-ttwe

  • Dosage Form:

    INJECTION, SOLUTION

  • Product Type:

    DRUG FOR FURTHER PROCESSING

  • Strength:

    130 mg/26mL

  • Substance:

    USTEKINUMAB

  • Start Marketing Date:

    2025-02-22

  • End Marketing Date:

    0000-00-00

  • DEA Schedule:

  • Certified Through:

    2026-12-31

PCAS

+16

  • NDC:

    68925-0010

  • Nonproprietary Name:

    SODIUM PHENYLBUTYRATE

  • Dosage Form:

    POWDER

  • Product Type:

    BULK INGREDIENT

  • Strength:

    1 kg/kg

  • Substance:

    SODIUM PHENYLBUTYRATE

  • Start Marketing Date:

    2024-01-01

  • End Marketing Date:

    0000-00-00

  • DEA Schedule:

  • Certified Through:

    2026-12-31

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit